Login
Contact

Explore

Explore

About
  • People and Partners
  • TRI Building
  • Reconciliation Action Plan
  • Strategic Plan
  • TRI Foundation
  • Careers
Research
  • Collaborate
  • Discovery
  • Translate
  • Engage
  • Research Areas
Clinical
  • Translational Trials
  • Clinical Research Facility
  • TRI at Children’s
Industry
  • TRI Incubator
  • The Precinct
  • Residents
Manufacture
  • New cGMP Facility
Facilities
  • Cleanroom
  • Flow Cytometry
  • Histology
  • Microscopy
  • Proteomics
  • Preclinical Imaging
  • Biological Research
  • Gnotobiotics
  • Human Immune Model
Get Involved
  • Health Consumers
  • SPARQ-ed
Resources
  • News
  • Events
  • Case Studies
  • Grants and Funding
  • Education and Training
+61 7 3443 7000info@tri.edu.au37 Kent Street, Woolloongabba QLD 4102 Australia

Acknowledgement of Country

TRI acknowledges the traditional custodians of the land we are on today, the Turrbal and Jagera people and we recognise their continuing connection to land, waters and community. We pay deep respect to them and their cultures; and to Elders past, present and emerging.

© Translational Research Institute Pty Ltd atf the Translational Research Institute Trust|ABN: 58 155 991 662
Privacy policy|Terms of Use|Contact Us
TRI · Research

Research

ResearchCollaborateDiscoveryTranslateEngageHealth ConsumersResearch Areas

TRI-based research: from bench to bedside

The work conducted at TRI is translational research, a research process which involves teams of patients, clinicians and researchers working together to solve health challenges faster. The work is driven by the needs of patients, a question formed by a clinician and a solution sought by a scientist. Also known as ‘bench-to-bedside’ research, it is a type of medical research that focuses on ‘translating’ basic science discoveries from the laboratory into improvements in how we detect, diagnose and treat health conditions for our communities.

Discover

Pre-clinical studies lead to research breakthroughs

Translate

Real world studies delivering population-level impact

Clinical Trials

Human prototype and evidence-based patient trials
Want to collaborate with a TRI-based researcher? Connect with a variety of Research Groups and Expertise.
Translation

The Translational Pathway Explained

For medical research discoveries that end up as products in our community and health system, there are many steps they need to take along the pathway to translation into solutions and better health outcomes.

Translation

The Translational Pathway Explained

For medical research discoveries that end up as products in our community and health system, there are many steps they need to take along the pathway to translation into solutions and better health outcomes.

Best in class research capability

World-class facilities

Infrastructure and innovation.

Clinical trial expertise

Prioritising patient-centred care.

Research areas

Accelerating research translation through collaboration - linking focus to specialisation.
CancerImmunologyChronic and severe diseasesNeurosciencesEmerging
research fields

Collaboration and engagement

Clinical Research and Translation Unit: Research, clinician, consumer and STEM engagement

The Research and Clinical Translation Unit is a key enabler of engagement at TRI. The Unit aims to create a collaborative, translational research ecosystem within TRI; upskill future research leaders; support clinicians in research; drive research impact and foster the next generation of researchers.

LINC Grant Scheme
Translation Pathways Program
Early and Mid-Career Researcher (EMCR) program
SPARQ-ed programs
Consumer and Community Involvement Program
TRI Affiliates

Engage with TRI

Glenda Colburn

Industry Development and Tenancy Manager
"I support industry growth and foster connections with research."

My role is to help grow networks and ensure the companies housed here can access the supports they need to mature their products for market – from introductions to venture capital firms, quality and regulatory checks, tax advice, IP attorneys, or clinical trial providers.
 
A key focus for me is enabling collaborations and initiatives that promote innovation, acceleration, and integration.

I am proud to be a part of these journeys and to be able to offer the world-class facilities, resources, and support services we provide at TRI.

Benedette Watson

Research & Clinical Translation Manager
"I empower people to collaborate and create impact."

My role is to aid and support researcher, clinician, and health consumer collaborations. At TRI, we recognize and celebrate these connections and the opportunities they create.

Specifically, I ensure researchers and clinicians have the right supports when and where they are needed most, through grants, educational and networking programs, and our TRI Affiliates Program.

As well I drive connections between researchers and health consumers ensuring understanding of the ‘lived experience’ is embedded in research practice for improved outcomes.

Julia Renaud

Research Engagement & Impact Manager
"I promote the growth and development of researchers and their work."

My role is to develop and implement programs to support and enable translational research across the continuum, from discovery to improved patient health outcomes. In particular, I work with early and mid-career researchers and clinicians based at TRI. 

I create training and educational opportunities and initiatives to drive collaborations across the broader ecosystem.

My key focus is to help deliver measurable impact on improving medical research outcomes.

Research Spotlight

Studying rising rates of Type 1 diabetes in children
Professor Josephine Forbes

Professor Jo Forbes from Mater Research says Type 1 diabetes in children is twice as common now than it was 20 years ago.

Smarter AI for skin cancer care
Professor Peter Soyer

Researchers from The University of Queensland have supported a study to improve the performance of an artificial intelligence (AI) model in skin cancer diagnosis and management.

Developing new cystic fibrosis treatment
Dr Timothy Wells

Researchers are determining the feasibility of a clinical trial for a new therapy to help improve the lifespan of people with cystic fibrosis.

Boost for deadly ovarian cancer vaccine
Professor Kristen Radford

Mater Research is set to spearhead the development of a ground-breaking vaccine to treat ovarian cancer thanks to a $670,000 OCRF (Ovarian Cancer Research Foundation) grant announced today.

Transforming healthcare with microbiome research
Professor Gene Tyson

TRI-based researchers from QUT are progressing our understanding of the human microbiome and its role in human health and disease.

Research Integrity and Ethics

TRI, our partners and all TRI-based researchers are committed to conducting and supporting methodologically and ethically sound research.

The National Health and Medical Research Council (NHMRC) is the key driver of health and medical research in Australia and is Australia’s leading expert body promoting the development and maintenance of public and individual health standards. It plays a key role in overseeing and measuring the knowledge, health, economic, and social impacts it supports by providing guidelines and advice on health and medical research ethics, and setting standards for conducting research.

TRI abides by NHMRCs Australian Code for the Responsible Conduct of Research 2018.

Need help collaborating? Looking to connect with a research group?

Need help collaborating? Looking to connect with a research group?